We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HYFM:NASDAQHydrofarm Holdings Group, Inc. Analysis

Data as of 2026-06-03 - not real-time

$0.96

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Hydrofarm Holdings Group (HYFM) is trading at $0.96, well below its 30‑day simple moving average of $1.00 and the 200‑day SMA of $1.94, indicating a prolonged downtrend. The 14‑day RSI sits at 44, suggesting modest bearish momentum but not yet oversold, while the MACD line remains under the signal line, producing a bearish histogram. Volatility is extreme at 86% over the past 30 days and beta is near market neutral at 1.0, meaning price swings are amplified without a clear directional bias. Trading volume has been decreasing, and the market cap is only $4.6 million, underscoring thin liquidity and heightened liquidity risk.
The latest Q1 2026 results reveal a 30% drop in revenue to $28.5 million and a gross margin that fell to 6.4%, with operating and net margins deeply negative. The company disclosed a stockholders’ equity deficit of $63 million, triggering a Nasdaq notice for non‑compliance with minimum equity requirements. DCF analysis values the firm at roughly $9 per share, a ten‑fold premium to the current price, but the balance sheet shows $160 million of debt against negligible cash and negative earnings per share. No dividend is paid, and the forward EPS remains negative, confirming that dividend sustainability is nonexistent.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish MACD and RSI below 50
  • Decreasing volume and thin trading liquidity
  • Negative earnings and operating margins

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant discount to DCF fair value
  • Potential upside if equity compliance is restored
  • Continued revenue contraction and cash burn

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Deep price discount offering speculative upside
  • Structural growth in controlled‑environment agriculture
  • Persistent balance‑sheet weakness and high debt load

Key Metrics & Analysis

Financial Health

Revenue Growth-29.60%
Profit Margin-237.25%
P/E Ratio-1.5
ROE-440.05%
ROA-10.05%
P/B Ratio-0.1
Op. Cash Flow$-3055000
Free Cash Flow$15.0M
Industry P/E30.1

Technical Analysis

TrendBearish
RSI43.8
Support$0.94
Resistance$1.32
MA 20$1.00
MA 50$1.01
MA 200$1.94
MACDBearish
VolumeDecreasing
Fear & Greed Index92.75

Valuation

Fair Value$8.98
GradeUndervalued
TypeValue

Risk Assessment

Beta1.01
Volatility86.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.